AMR presents challenges in treatment, costs, and mortality rates compared with non-resistant infections in humans and animals. Despite the efforts to assess and control AMR, challenges remain because of uncertainties in data acquisition and dose-response mechanisms. To streamline the estimation process and minimize labor, a study developed three ML models (LR, DT, and RF)